348 related articles for article (PubMed ID: 26299616)
1. Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
Gaiser MR; Daily K; Hoffmann J; Brune M; Enk A; Brownell I
Oncotarget; 2015 Sep; 6(28):26472-82. PubMed ID: 26299616
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.
Blom A; Bhatia S; Pietromonaco S; Koehler K; Iyer JG; Nagase K; Paulson K; Sabath DE; Nghiem P
J Am Acad Dermatol; 2014 Mar; 70(3):449-55. PubMed ID: 24388423
[TBL] [Abstract][Full Text] [Related]
3. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study.
Zaragoza J; Kervarrec T; Touzé A; Avenel-Audran M; Beneton N; Esteve E; Wierzbicka Hainaut E; Aubin F; Machet L; Samimi M
J Am Acad Dermatol; 2016 Oct; 75(4):712-721.e1. PubMed ID: 27544490
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
van Veenendaal LM; Bertolli E; Korse CM; Klop WMC; Tesselaar MET; van Akkooi ACJ
Ann Surg Oncol; 2021 Feb; 28(2):1019-1028. PubMed ID: 32529274
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cell Detection and Polyomavirus Status in Merkel Cell Carcinoma.
Boyer M; Cayrefourcq L; Garima F; Foulongne V; Dereure O; Alix-Panabières C
Sci Rep; 2020 Jan; 10(1):1612. PubMed ID: 32005907
[TBL] [Abstract][Full Text] [Related]
7. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE
J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
[TBL] [Abstract][Full Text] [Related]
9. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
[TBL] [Abstract][Full Text] [Related]
10. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.
Lim CS; Whalley D; Haydu LE; Murali R; Tippett J; Thompson JF; Hruby G; Scolyer RA
Ann Surg Oncol; 2012 Oct; 19(11):3325-34. PubMed ID: 22820936
[TBL] [Abstract][Full Text] [Related]
11. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
[TBL] [Abstract][Full Text] [Related]
13. Re: Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase.
Dittadi R; Gion M
Clin Biochem; 2013 Aug; 46(12):1145. PubMed ID: 23608355
[No Abstract] [Full Text] [Related]
14. Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Yao JC; Pavel M; Phan AT; Kulke MH; Hoosen S; St Peter J; Cherfi A; Öberg KE
J Clin Endocrinol Metab; 2011 Dec; 96(12):3741-9. PubMed ID: 21994954
[TBL] [Abstract][Full Text] [Related]
15. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract][Full Text] [Related]
16. LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers.
Sundqvist B; Sihto H; von Willebrand M; Böhling T; Koljonen V
Virchows Arch; 2021 Dec; 479(6):1197-1207. PubMed ID: 34331569
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
Jouary T; Kubica E; Dalle S; Pages C; Duval-Modeste AB; Guillot B; Mansard S; Saiag P; Aubin F; Bedane C; Dalac S; Dompmartin A; Granel-Brocard F; Lok C; Stoebner PE; Lacour JP; Leccia MT; Diallo A; Ezzedine K; Mateus C
Acta Derm Venereol; 2015 Sep; 95(7):835-40. PubMed ID: 25784178
[TBL] [Abstract][Full Text] [Related]
18. Merkel Cell Carcinoma of the Buccal Mucosa and Lower Lip.
Islam MN; Chehal H; Smith MH; Islam S; Bhattacharyya I
Head Neck Pathol; 2018 Jun; 12(2):279-285. PubMed ID: 28980225
[TBL] [Abstract][Full Text] [Related]
19. Merkel cell carcinomas infiltrated with CD33
Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of EZH2 in Merkel cell carcinoma is associated with disease progression and poorer prognosis.
Harms KL; Chubb H; Zhao L; Fullen DR; Bichakjian CK; Johnson TM; Carskadon S; Palanisamy N; Harms PW
Hum Pathol; 2017 Sep; 67():78-84. PubMed ID: 28739498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]